Perbandingan Efektivitas Dan Keamanan Jangka Panjang Antara Dabigatran, Rivaroxaban, Apixaban, dan Edoxaban Pada Pasien Atrial Fibrilasi: Studi Kohort Nasional – Telaah Jurnal Alomedika

Oleh :
dr.Eduward Thendiono, SpPD,FINASIM

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study

Grymonprez M De Backer TL, Bertels X, Steurbaut S and Lahousse L. Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study. Front. Pharmacol. 2023.14:1125576. doi: 10.3389/fphar.2023.1125576

Abstrak

Referensi